Related Experiment Video
Updated: Sep 14, 2025
03:56
Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
764
Long noncoding RNA LINC00339 promotes osteoporosis development via modulating of regulator CDC42 by binding PARP1
Dong-Li Zhu1,2, Yan Zhang1, Xiao-Yu Zhang1
1Key Laboratory of Biomedical Information Engineering of Ministry of Education, Biomedical Informatics & Genomics Center, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, PR China.
Non-Coding RNA Research
|July 24, 2025
Summary
This study identifies a novel LINC00339-PARP1-CDC42 regulatory axis in osteoporosis. This pathway, involving long non-coding RNA LINC00339 and protein PARP1, impacts osteoblast function and bone remodeling, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Bone Biology
Background:
- Osteoporosis is a skeletal disorder marked by decreased bone mass and tissue deterioration.
- Long non-coding RNA LINC00339 is implicated in osteoporosis pathogenesis via unknown molecular pathways.
- Understanding LINC00339's role in bone remodeling is crucial for developing new osteoporosis treatments.
Purpose of the Study:
- To investigate the mechanistic role of LINC00339 in osteoporosis.
- To identify molecular interactions and pathways involving LINC00339 in bone cells.
- To explore LINC00339 as a potential therapeutic target for osteoporosis.
Main Methods:
- Quantitative reverse transcription PCR (qRT-PCR) to assess LINC00339 expression in bone tissues.
- Alkaline phosphatase (ALP) and Alizarin Red S (ARS) staining to evaluate osteogenic differentiation in manipulated cell lines.
- RNA fluorescence in situ hybridization (FISH) to determine LINC00339 subcellular localization.
- RNA-protein pull-down, RNA immunoprecipitation (RIP), and Co-immunoprecipitation (Co-IP) assays to investigate molecular interactions and mechanisms.
Main Results:
- LINC00339 was significantly upregulated in bone tissues of osteoporosis patients.
- LINC00339 dysregulation inversely correlated with osteogenic differentiation capacity in osteoblast models.
- LINC00339 predominantly localizes in the cytoplasm of bone cells.
- The LINC00339-PARP1 (poly (ADP-Ribose) polymerase 1) axis was identified as a key regulator of bone homeostasis.
- LINC00339 and PARP1 were found to co-regulate CDC42 (cell division cycle 42) expression via post-transcriptional mechanisms.
Conclusions:
- A novel LINC00339-PARP1-CDC42 regulatory axis contributes to osteoporosis pathogenesis.
- This axis advances the understanding of epigenetic regulation in bone remodeling.
- The LINC00339-PARP1 interaction presents a potential therapeutic target for osteoporosis.
- Targeting RNA-protein complexes offers a promising strategy for skeletal disorder interventions.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
00:50Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
01:20The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
01:40Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K